Like generic drugs, biosimilars offer a lower-cost opportunity to treat expensive diseases and illnesses. They are some of the most innovative physician-administered drugs and are successfully treating complex diseases like cancer, rheumatoid arthritis, Crohn's disease, and ulcerative colitis. The
"This legislation represents an important step toward containing drug prices for some of the most expensive therapies. By increasing patient access and encouraging development of more biosimilars this legislation would save Medicare beneficiaries and taxpayers billions of dollars," said Rep.
"Every day I hear from Upstate New Yorkers who cannot afford the medication they need, and it is way past time for